Air Liquide ALIAD
VC Fund
Paris, France
Air Liquide ALIAD is a VC fund in Paris focused on Manufacturing and Electronics. Air Liquide Investments in the future and demonstration (ALIAD), is a 100% Air Liquide subsidiary integrated in the Group’s new network Advanced Business and Technologies entrepreneurial companies.ALIAD contributes to the Group’s growth and competitiveness by investing in young innovative companies offering new technologies. By placinginvestments in a dedicated subsidiary, Air Liquide ensures itself all the means for developing these projects with the necessary flexibility and reactivity.
- Total investments:
- 18
- Last investment:
- Lead investor:
- 28%
Last updated:
For AI agents: llms.txt
Industries Air Liquide ALIAD invests in
Stages Air Liquide ALIAD invests in
Countries Air Liquide ALIAD invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $223k–$5.4M
- Series A
- $7.4M–$16M
- Series B
- $4.2M–$34M
Investment Focus
Industry
- Manufacturing 6 (33%)
- Electronics 4 (22%)
- Health Care 4 (22%)
- Oil and Gas 3 (17%)
- Medical 2 (11%)
Stage
- Series B 8 (44%)
- Seed 3 (17%)
- Series A 2 (11%)
- Venture - Series Unknown 2 (11%)
- Series C 1 (6%)
Country
- France 6 (33%)
- United States 4 (22%)
- Italy 1 (6%)
- Spain 1 (6%)
- Belgium 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Greg Fleming
Investment Director
|
Investment Director | Total investments: 0 | Find email | |
|
Nadia El Andaloussi
Investment Manager
|
Investment Manager | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Ekoscan Integrity
|
Ekoscan Integrity is an innovative solution for the integrity and sustainability of industrial products through the implementation of innovative technology. | Venture - Series Unknown / Apr 10, 2025 | |
Noble Gas Systems
|
Noble Gas Systems develops gas storage and delivery systems with conformable tank technology. The company was founded in 2017 and is headquartered in Novi, Michigan. | $4.2M / Series B / Mar 19, 2025 | |
Angiodroid
|
Angiodroid srl, a medical technology company, focuses on hemodynamics, vascular surgery, and interventional radiology. It offers an automatic injection system for carbon dioxide angiography. Its products include carbon dioxide injector that is used as a contrast medium for pheriperal interventional angiography; and a single use kit, which iscomposed of French catheters and a custom connection line. The company is based in San Lazzaro di Savena, Italy. | $7.4M / Series A / Feb 27, 2023 | |
SparkNano
|
Our spatial ALD technology enables customers to design and mass produce the next generation energy- and display devices more efficiently | $5.4M / Seed / Nov 03, 2022 | |
BOTALYS
|
OUR MISSIONWe are Botanical Explorers seeking the next frontier of plant health benefits while preserving wild biotopes. We firmly believe that medicinal plants deserve a new standard of uncompromising quality, and we are committed to explore their health potential further while respecting the planet. Hence, our two core values: Explore &Respect.OUR VISIONIndoor Precision Farming offers a unique opportunity to sustainably grow potent medicinal plants. We have developed our own indoor farming approach under ultra-clean conditions. Our cultivation facilities are one of the largest vertical farms in Europe. There, by optimizing the growth environment, we ensure that our botanicals reach their full potential in terms of Health benefits, bringing full-spectrum product to the next level, and combining Wild Quality with Lab purity.OUR PRODUCTWith more than 3000 years of medicinal tradition and more than 5000 scientific publications about its health benefits, Korean red ginseng (Panax ginseng CA Meyer) is, without a doubt, the most precious and revered medicinal plant in the world. At BOTALYS, we are shaping its molecular profile, making our full-spectrum ginseng root powder comparable to a 20 years old wild Korean ginseng specimen.And ginseng is just the first botanical milestone of our journey… | $6.6M / Series B / Oct 04, 2022 | |
|
BOTALYS
|
OUR MISSIONWe are Botanical Explorers seeking the next frontier of plant health benefits while preserving wild biotopes. We firmly believe that medicinal plants deserve a new standard of uncompromising quality, and we are committed to explore their health potential further while respecting the planet. Hence, our two core values: Explore &Respect.OUR VISIONIndoor Precision Farming offers a unique opportunity to sustainably grow potent medicinal plants. We have developed our own indoor farming approach under ultra-clean conditions. Our cultivation facilities are one of the largest vertical farms in Europe. There, by optimizing the growth environment, we ensure that our botanicals reach their full potential in terms of Health benefits, bringing full-spectrum product to the next level, and combining Wild Quality with Lab purity.OUR PRODUCTWith more than 3000 years of medicinal tradition and more than 5000 scientific publications about its health benefits, Korean red ginseng (Panax ginseng CA Meyer) is, without a doubt, the most precious and revered medicinal plant in the world. At BOTALYS, we are shaping its molecular profile, making our full-spectrum ginseng root powder comparable to a 20 years old wild Korean ginseng specimen.And ginseng is just the first botanical milestone of our journey… | $271K / Secondary Market / Oct 04, 2022 | |
Inpria
|
Inpria Corporation is a pioneer in extending semiconductor lithography with inorganic photoresists and other thin-films for nanoscale patterning. Inpria’s patented photo-condensed molecular oxides offer customers the unique ability to deposit – directly from solution – atomically smooth, intrinsically dense, and directly photopatternable metaloxide films, enabling advanced performance with simplified processing. | $31M / Series C / Feb 21, 2020 | |
Diabeloop
|
Diabeloop is a medical device company for diabetes and closed-loop system. It also develops disruptive technological innovations to automate the treatment of diabetes.The company mission is to make accessible disruptive technological innovations that will allow people with type 1 diabetes to live the life they want. Diabeloop was founded in 2015and is headquartered in Grenoble, Auvergne-Rhône-Alpes, France. | $34.3M / Series B / Dec 02, 2019 | |
Ergosup
|
Ergosup developes an innovative process for producing high pressure hydrogen on site for refueling hydrogen fuel vehicles. | $12.4M / Series B / Feb 18, 2019 | |
MYSPHERA
|
MYSPHERA provides award-winning open Internet of Things for Healthcare solutions to acute care hospitals, senior living organizations, and patient homes around the world. MYSPHERA solutions empower Clinicians, Patients, and Healthcare Management with smart sensor-driven on-demand actionable information to improve patient care outcomes whileincreasing efficient management of resources in hospitals, senior living residences, and patient homesMYSPHERA provides its breathrough solutions to healthcare organizations in Europe, Middle East and Latin America. | $2.9M / Venture - Series Unknown / Sep 27, 2018 | |
| See all 18 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Air Liquide ALIAD invest in?
Air Liquide ALIAD invests primarily in Manufacturing, Electronics and Health Care startups, most often at Series B and Seed stage. Most of the 18 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Air Liquide ALIAD's check size?
Air Liquide ALIAD typically joins rounds of $223k–$5.4M at Seed, $7.4M–$16M at Series A and $4.2M–$34M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Air Liquide ALIAD participates in.
How do I contact Air Liquide ALIAD?
Public channels for Air Liquide ALIAD include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Air Liquide ALIAD?
The team at Air Liquide ALIAD includes Greg Fleming (Investment Director) and Nadia El Andaloussi (Investment Manager). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
